Reducing Your Risk of Cervical Cancer
- Talk to your doctor about Pap tests.
- Practice safe sex.
- Ask your doctor about the HPV vaccine.
- Do not smoke.
- Eat a balanced diet.
- If you are aged 21-29 years, it is recommended that you have the Pap test every three years.
- If you are aged 30 or older, you should have a Pap test along with a test to check for the human papillomavirus (HPV) every 5 years. Alternatively, you may have the Pap test alone every three years.
- If you are aged 65 or older, you may be able to stop having the Pap tests done if you have had normal results for the past three Pap tests and no abnormal results for the past 10 years.
- Gardasil—reduces the risk of:
- Cervarix—reduces the risk of cervical cancer and cervical pre-cancer
American College of Obstetricians and Gynecologists. First cervical cancer screening delayed until age 21 less frequent Pap tests recommended. American College of Obstetricians and Gynecologists website. Available at: http://www.acog.org. Published November 20, 2009. Accessed November 23, 2009.
Baker CJ, Pickerling LK, et al. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2011. Ann Intern Med. 2011;154(3):168-173.
Cervarix. GlaxoSmithKline Cervarix website. Available at: http://www.cervarix.com. Accessed December 23, 2009.
Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years—United States, 2011. MMWR. 2011;60(5).
Grady D. Guidelines push back age for cervical cancer tests. The New York Times website. Available at: http://www.nytimes.com/2009/11/20/health/20pap.html?%5Fr=1. Published November 20, 2009. Accessed November 23, 2009.
National Cancer Institute website. Available at: http://www.cancer.gov.
Recommended adult immunization schedule—United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;6(4). Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/adult/mmwr-adult-schedule.pdf. Accessed February 24, 2012.
5/18/2007 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.
2/5/2013 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: American College of Obstetricians and Gynecologists practice bulletin number 131: Screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222-38.
- Reviewer: Mohei Abouzied, MD, FACP
- Review Date: 12/2014 -
- Update Date: 12/20/2014 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.